补助 发表于 2025-3-25 06:52:03

http://reply.papertrans.cn/1/96/9569/9569-21.png

评论性 发表于 2025-3-25 10:16:52

Submitted on: 25 June 2012.
Revised on: 19 August 2012.
Accepted on: 03 September 2012.

___________________Expert Review of Neurotherapeutics

legacy 发表于 2025-3-25 14:29:12

http://reply.papertrans.cn/1/96/9569/9569-23.png

Barrister 发表于 2025-3-25 18:25:40

Submitted on: 17 September 2003.
Revised on: 18 December 2003.
Accepted on: 01 January 2004.

___________________Expert Review of Neurotherapeutics

ASTER 发表于 2025-3-25 20:38:40

http://reply.papertrans.cn/1/96/9569/9569-25.png

attenuate 发表于 2025-3-26 03:05:46

Submitted on: 03 July 2006.
Revised on: 26 July 2006.
Accepted on: 31 August 2006.

___________________Expert Review of Neurotherapeutics

Kaleidoscope 发表于 2025-3-26 04:20:14

Submitted on: 29 July 2024.
Revised on: 19 November 2024.
Accepted on: 05 December 2024.

___________________Expert Review of Neurotherapeutics

标准 发表于 2025-3-26 10:40:26

http://reply.papertrans.cn/1/96/9569/9569-28.png

forebear 发表于 2025-3-26 14:47:11

Submitted on: 17 September 2019.
Revised on: 24 December 2019.
Accepted on: 14 January 2020.

___________________Expert Review of Neurotherapeutics

鲁莽 发表于 2025-3-26 17:19:00

Submitted on: 09 March 2002.
Revised on: 26 May 2002.
Accepted on: 07 July 2002.

___________________Expert Review of Neurotherapeutics
页: 1 2 [3] 4
查看完整版本: SCIE期刊Expert Review of Neurotherapeutics 2024/2025影响因子:3.494 (EXPERT REV NEUROTHER) (1473-7175). (CLINICAL NEUROLOGY)(临